Yili Chuanning Biotechnology Co.,Ltd. (SHE:301301)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Medicine Manufacturing	5.40B	4.51B	3.57B	3.05B	-
Medicine Manufacturing Growth	19.53%	26.32%	16.99%	-	-
Unallocated Other	361.61M	308.58M	246.72M	177.08M	-
Unallocated Other Growth	17.19%	25.07%	39.33%	-	-
6-Aminopenicillanic Acid	-	-	-	-	885.13M
6-Aminopenicillanic Acid Growth	-	-	-	-	2.65%
7-Aminocephalosporanic Acid	-	-	-	-	580.51M
7-Aminocephalosporanic Acid Growth	-	-	-	-	-8.60%
Erythromycin Thiocyanate	-	-	-	-	1.17B
Erythromycin Thiocyanate Growth	-	-	-	-	51.32%
Penicillin G Potassium Salt	-	-	-	-	402.74M
Penicillin G Potassium Salt Growth	-	-	-	-	31.64%
Deacetyl-7-Aminocephalosporanic Acid	-	-	-	-	210.80M
Deacetyl-7-Aminocephalosporanic Acid Growth	-	-	-	-	-18.04%
7-Aminodeacetoxycephalosporanic Acid	-	-	-	-	114.57M
Ursodeoxycholic Acid	-	-	-	-	2.94M
Ursodeoxycholic Acid Growth	-	-	-	-	-81.29%
Total	5.76B	4.82B	3.82B	3.23B	3.37B
Total Growth	19.38%	26.24%	18.21%	-3.98%	18.15%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Central China	333.33M	103.19M	327.48M	304.87M	-
Central China Growth	223.03%	-68.49%	7.42%	-	-
East China	2.40B	2.17B	1.26B	668.49M	-
East China Growth	10.52%	71.85%	89.05%	-	-
North China	1.51B	1.25B	1.15B	1.13B	-
North China Growth	21.20%	8.39%	1.94%	-	-
Export	523.33M	574.89M	295.41M	563.08M	-
Export Growth	-8.97%	94.61%	-47.54%	-	-
Southwest	82.17M	269.56M	249.51M	216.25M	-
Southwest Growth	-69.52%	8.03%	15.38%	-	-
Northwest	396.93M	310.97M	244.68M	229.38M	-
Northwest Growth	27.64%	27.09%	6.67%	-	-
South China	406.86M	78.73M	153.55M	54.30M	-
South China Growth	416.80%	-48.73%	182.81%	-	-
Northeast	102.50M	65.83M	134.33M	65.75M	-
Northeast Growth	55.71%	-51.00%	104.31%	-	-
Southeast	-	-	94.34K	14.13K	-
Southeast Growth	-	-	567.65%	-	-
China	-	-	-	-	3.65B
China Growth	-	-	-	-	16.10%
Total	5.76B	4.82B	3.82B	3.23B	3.65B
Total Growth	19.38%	26.24%	18.21%	-11.44%	16.10%

Source: S&P Global Market Intelligence.